The purpose of this study is to evaluate biomarkers of exposure and potential harm between those who smoke conventional cigarettes and those who switch to an investigational e-cigarette.
Duration: Up to 14 weeks
Number of Office Visits: Up to 6 with up to 3 being in-clinic stays
Compenstation: Between $650.00 and $3,910.00 (depending on assigned study group)
NOTE: Qualified participants must be healthy adults 21 to 65 years old who smoke an average of 5 or more conventional cigarettes per day for at least the past year. Participants must also have the ability to stay in-clinic 24-hours a day up to 3 separate times. Other criteria apply.
*Indicates required question. Some of these questions may be sensitive in nature. You do not have to answer any questions you don't want to and you may end this questionnaire at any time.